Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer
- PMID: 19593573
- DOI: 10.1007/s00384-009-0755-6
Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer
Abstract
Purpose: Survivin has been shown to be an important mediator of cellular radioresistance in vitro. This study aims to compare survivin expression and apoptosis to histomorphologic responses to neoadjuvant radiochemotherapy (RCT) in rectal cancer.
Materials and methods: Thirty-six pre-treatment biopsies were studied. Survivin mRNA and protein expression plus TUNEL staining for apoptosis was performed. Response to treatment was assessed using a 5-point tumour regression grade.
Results: Survivin expression was not found to be predictive of response to RCT (p = NS). In contrast, spontaneous apoptosis was significantly (p = 0.0051) associated with subsequent response to RCT. However, no association between survivin expression and levels of apoptosis could be identified.
Conclusions: This in vivo study failed to support in vitro studies showing an association between survivin and response to chemotherapy and radiation therapy. These results caution against the translation of the in vitro properties of survivin into a clinical setting.
Similar articles
-
High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.Strahlenther Onkol. 2002 Aug;178(8):426-35. doi: 10.1007/s00066-002-1003-y. Strahlenther Onkol. 2002. PMID: 12240548
-
Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival.Clin Cancer Res. 2011 Mar 15;17(6):1623-31. doi: 10.1158/1078-0432.CCR-10-2592. Epub 2010 Nov 30. Clin Cancer Res. 2011. PMID: 21118954 Clinical Trial.
-
Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer.Pharmacogenomics. 2008 Jun;9(6):681-90. doi: 10.2217/14622416.9.6.681. Pharmacogenomics. 2008. PMID: 18518847
-
Neoadjuvant radiochemotherapy in rectal cancer: for which patients and tumor stages?Front Radiat Ther Oncol. 2004;38:13-23. doi: 10.1159/000078259. Front Radiat Ther Oncol. 2004. PMID: 15458182 Review. No abstract available.
-
Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy.Eur J Surg Oncol. 2006 Feb;32(1):55-64. doi: 10.1016/j.ejso.2005.09.010. Epub 2005 Dec 1. Eur J Surg Oncol. 2006. PMID: 16324817 Review.
Cited by
-
High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer.Int J Colorectal Dis. 2011 Aug;26(8):1019-23. doi: 10.1007/s00384-011-1180-1. Epub 2011 Mar 19. Int J Colorectal Dis. 2011. PMID: 21424389
-
Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer.Surg Today. 2011 Feb;41(2):175-82. doi: 10.1007/s00595-010-4390-1. Epub 2011 Jan 26. Surg Today. 2011. PMID: 21264751 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous